124 related articles for article (PubMed ID: 9377062)
1. [Use of photoactivation in the preparation of radiopharmaceuticals. II. Dialysate of human leukocytes labelled with technetium (99mTc)].
Kleisner I; Komárek P; Konopková M; Komárková I
Ceska Slov Farm; 1997 Aug; 46(4):169-73. PubMed ID: 9377062
[TBL] [Abstract][Full Text] [Related]
2. [Use of photoactivation in the preparation of radiopharmaceuticals. I. Human immunoglobulin labelled with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárko I
Ceska Slov Farm; 1997 Jun; 46(3):122-7. PubMed ID: 9440949
[TBL] [Abstract][Full Text] [Related]
3. [Use of photoactivation in the preparation of radiopharmaceuticals. III. Human serum albumin labelled with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 1997 Oct; 46(5):217-21. PubMed ID: 9600144
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of radiolabelled low molecular peptides and proteins in experimental inflammation.
Komarek P; Kleisner I; Komarkova I; Konopkova M
Int J Pharm; 2005 Mar; 291(1-2):119-25. PubMed ID: 15707738
[TBL] [Abstract][Full Text] [Related]
5. A new technique of 99mTc-ciprofloxacin kit preparation.
Kleisner I; Komarek P; Komarkova I; Konopkova M
Nuklearmedizin; 2002 Oct; 41(5):224-9. PubMed ID: 12418309
[TBL] [Abstract][Full Text] [Related]
6. The use of redox polymers in labelling procedures of proteins and peptides with 99mTc. II. Technique of preparation of kits for protein labelling by 99mTc and its effect on the stability and radiochemical purity.
Komárek P; Kleisner I; Komárková I; Konopková M
Nucl Med Rev Cent East Eur; 2000; 3(1):69-72. PubMed ID: 14600985
[TBL] [Abstract][Full Text] [Related]
7. [Biodistribution of low-molecular-weight proteins and technetium (99mTc) labeled peptides in an animal model of inflammation].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 2002 Sep; 51(5):252-6. PubMed ID: 12407925
[TBL] [Abstract][Full Text] [Related]
8. [Labeling products of photochemical degradation of insulin with technetium (99mTc)].
Kleisner I; Komárek P; Klancík J; Konopková M; Komárková I
Ceska Slov Farm; 2000 Mar; 49(2):91-5. PubMed ID: 10953451
[TBL] [Abstract][Full Text] [Related]
9. [Use of redox polymers for insulin labeling with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 1999 Sep; 48(5):218-20. PubMed ID: 10566241
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
[TBL] [Abstract][Full Text] [Related]
12. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
[TBL] [Abstract][Full Text] [Related]
13. Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats.
Xavier Holanda CM; Cavalcanti Jales RL; Almeida Catanho MT; Holanda Leite RC; Lopes de Brito LM; Jales-Junior LH; Brandao KC; Amorim LF; de Brito Tiago GG; Gomes ML; Bernardo-Filho M
Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):761-5. PubMed ID: 12619972
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biodistribution studies of two novel radiolabeled estrone derivatives.
Enginar H; Unak P; Lambrecht FY; Biber Muftuler FZ; Medine EI
In Vivo; 2008; 22(1):93-100. PubMed ID: 18396789
[TBL] [Abstract][Full Text] [Related]
15. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m radiopharmaceutical preparation problems: 12 years of experience.
Ponto JA
J Nucl Med Technol; 1998 Dec; 26(4):262-4. PubMed ID: 9884939
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
[TBL] [Abstract][Full Text] [Related]
18. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
19. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
Vucina J
Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes.
Hung JC; Iverson BC; Toulouse KA; Mahoney DW
J Nucl Med; 2002 Jul; 43(7):928-32. PubMed ID: 12097465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
